Dailenys Marrero-Morfa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dailenys Marrero-Morfa has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alejandra Rojas-Molina
Facultad de Ingeniería, Universidad Autónoma de Querétaro, Querétaro 76010, Mexico
2 shared publications - César Ibarra-Alvarado
Laboratorio de Investigación Química y Farmacológica de Productos Naturales, Facultad de Química, Universidad Autónoma de Querétaro, Querétaro 76010, Mexico
2 shared publications - Francisco Javier Luna Vázquez
Universidad Autónoma de Querétaro, Facultad de Química
2 shared publications - Victoria Ruiz-Castillo
Posgrado en Ciencias Químico Biológicas, Facultad de Química, Universidad Autónoma de Querétaro, Cerro de las Campanas S/N, Santiago de Querétaro C.P. 76010, Querétaro, Mexico
2 shared publications - Beatriz A. Luz-Martínez
Posgrado en Ciencias Químico Biológicas, Facultad de Química, Universidad Autónoma de Querétaro, Querétaro 76010, Mexico
1 shared publication - Carlos Daniel Martínez-Hernández1 shared publication
Latest Publications
- Open Access
- 26 March 2026
- Published by Springer Nature in Journal of Food Measurement and Characterization
- Vol. 20 (5) , 8202-8216
Development and validation of a UV–Vis spectrophotometric method for the quantification of affinin in ethanolic extracts of Heliopsis longipes and commercial herbal products
Affinin, the main bioactive compound of Heliopsis longipes root, is an alkamide known for its multiple pharmacological effects, including anti-inflammatory, antihypertensive, and analgesic. Accurate quantification of affinin in extracts and commercial products is essential to ensure their quality and efficacy. In this study, a simple, robust, and accessible UV-Vis spectrophotometric method was developed and validated for the quantification of affinin in H. longipes ethanolic extracts and five marketed formulations in Mexico, and its performance was benchmarked against the gold-standard HPLC method. A linear calibration curve was established over 0.5 to 10 µg/mL, and the method was validated by evaluating linearity, accuracy, precision, specificity, and limits of detection (LOD) and quantification (LOQ). The maximum absorbance of affinin was determined at 230 nm in ethanol. Linearity was confirmed over the range of 0.5–10 µg/mL, with a correlation coefficient (R²) of 0.998. Precision, evaluated as intra- and inter-day reproducibility, showed relative standard deviations below 2%. Method accuracy was confirmed by standard addition experiments, with recovery values ranging from 98 to 102%. Specificity was supported by the absence of significant spectral interference in the UV spectra of the extract compared to the affinin standard, with an absorbance of 0.6795 ± 0.0026. The method also demonstrated adequate sensitivity, with LOD and LOQ of 0.298 µg/mL and 0.903 µg/mL, respectively. Affinin quantification in commercial formulations revealed variability in content, highlighting the need for rigorous quality control to ensure consistency among products. In conclusion, the validated UV–Vis method provides a rapid, cost-effective, and reliable tool for the quality control and standardization of H. longipes extracts and commercial products. Moreover, its use of ethanol as a bio-based solvent, low solvent consumption, and minimal waste generation align with green analytical chemistry principles, supporting more sustainable and accessible quality-control practices in the growing herbal product market.
- 26 March 2026
- Published by Springer Nature in Journal of Food Measurement and Characterization
- Vol. 20 (5) , 8202-8216
Open AccessDevelopment and validation of a UV–Vis spectrophotometric method for the quantification of affinin in ethanolic extracts of Heliopsis longipes and commercial herbal products
Affinin, the main bioactive compound of Heliopsis longipes root, is an alkamide known for its multiple pharmacological effects, including anti-inflammatory, antihypertensive, and analgesic. Accurate quantification of affinin in extracts and commercial products is essential to ensure their quality and efficacy. In this study, a simple, robust, and accessible UV-Vis spectrophotometric method was developed and validated for the quantification of affinin in H. longipes ethanolic extracts and five marketed formulations in Mexico, and its performance was benchmarked against the gold-standard HPLC method. A linear calibration curve was established over 0.5 to 10 µg/mL, and the method was validated by evaluating linearity, accuracy, precision, specificity, and limits of detection (LOD) and quantification (LOQ). The maximum absorbance of affinin was determined at 230 nm in ethanol. Linearity was confirmed over the range of 0.5–10 µg/mL, with a correlation coefficient (R²) of 0.998. Precision, evaluated as intra- and inter-day reproducibility, showed relative standard deviations below 2%. Method accuracy was confirmed by standard addition experiments, with recovery values ranging from 98 to 102%. Specificity was supported by the absence of significant spectral interference in the UV spectra of the extract compared to the affinin standard, with an absorbance of 0.6795 ± 0.0026. The method also demonstrated adequate sensitivity, with LOD and LOQ of 0.298 µg/mL and 0.903 µg/mL, respectively. Affinin quantification in commercial formulations revealed variability in content, highlighting the need for rigorous quality control to ensure consistency among products. In conclusion, the validated UV–Vis method provides a rapid, cost-effective, and reliable tool for the quality control and standardization of H. longipes extracts and commercial products. Moreover, its use of ethanol as a bio-based solvent, low solvent consumption, and minimal waste generation align with green analytical chemistry principles, supporting more sustainable and accessible quality-control practices in the growing herbal product market.
- Open Access
Antihypertensive Effect of a Self-Microemulsifying System Obtained from an Ethanolic Extract of Heliopsis longipes Root in Spontaneously and L-NAME-Induced Hypertensive Rats
Arterial hypertension is a major contributor to cardiovascular disease, the leading cause of death globally. Previously, our research group has demonstrated that both organic extracts from Heliopsis longipes roots and affinin—its principal bioactive compound—induce vasodilation and exert antihypertensive effects in L-NAME-induced hypertensive rats. However, the poor water solubility of these extracts limits their oral administration and dosing. To address this limitation, a self-microemulsifying drug delivery system (HL-SMDS) was developed from an ethanolic extract of H. longipes root to enhance its aqueous solubility and oral bioavailability. This study evaluated the antihypertensive efficacy of HL-SMDS in spontaneously hypertensive and L-NAME-induced hypertensive rat models, as well as its effects on endothelial reactivity. HL-SMDS significantly reduced systolic blood pressure in both models, demonstrating greater efficacy than the crude extract, likely due to improved solubility and systemic bioavailability of the active constituents. Moreover, HL-SMDS enhanced endothelial function in aortas from L-NAME-treated rats. These findings support the potential of HL-SMDS as a lipid-based phytopharmaceutical formulation that improves the oral bioavailability and antihypertensive effect of the ethanolic extract of H. longipes root. HL-SMDS offers a promising strategy for the development of phytopharmaceutical drugs to treat hypertension.
Open AccessAntihypertensive Effect of a Self-Microemulsifying System Obtained from an Ethanolic Extract of Heliopsis longipes Root in Spontaneously and L-NAME-Induced Hypertensive Rats
Arterial hypertension is a major contributor to cardiovascular disease, the leading cause of death globally. Previously, our research group has demonstrated that both organic extracts from Heliopsis longipes roots and affinin—its principal bioactive compound—induce vasodilation and exert antihypertensive effects in L-NAME-induced hypertensive rats. However, the poor water solubility of these extracts limits their oral administration and dosing. To address this limitation, a self-microemulsifying drug delivery system (HL-SMDS) was developed from an ethanolic extract of H. longipes root to enhance its aqueous solubility and oral bioavailability. This study evaluated the antihypertensive efficacy of HL-SMDS in spontaneously hypertensive and L-NAME-induced hypertensive rat models, as well as its effects on endothelial reactivity. HL-SMDS significantly reduced systolic blood pressure in both models, demonstrating greater efficacy than the crude extract, likely due to improved solubility and systemic bioavailability of the active constituents. Moreover, HL-SMDS enhanced endothelial function in aortas from L-NAME-treated rats. These findings support the potential of HL-SMDS as a lipid-based phytopharmaceutical formulation that improves the oral bioavailability and antihypertensive effect of the ethanolic extract of H. longipes root. HL-SMDS offers a promising strategy for the development of phytopharmaceutical drugs to treat hypertension.